Chen, L., Yang, G., & Dong, H. (2019). Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway. Med Sci Monit.
Chicago-стиль цитированияChen, Lin, Guangsheng Yang, and Hongming Dong. "Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells By Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway." Med Sci Monit 2019.
MLA-цитированиеChen, Lin, Guangsheng Yang, and Hongming Dong. "Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells By Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway." Med Sci Monit 2019.